|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q3 FY2013
As of Sep 30, 2013
|
Q2 FY2013
As of Jun 30, 2013
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Fixed maturities, at fair value (amortized cost: 2023, $16,604,693; 2022 $14,925,319) | ||||||||||||||||||||
| Short-term investments, at fair value (amortized cost: 2023, $1,032,895; 2022, $536,139) | ||||||||||||||||||||
| Equities, at fair value (cost: 2023, $532,484; 2022, $586,107) | ||||||||||||||||||||
| Investments in real estate | ||||||||||||||||||||
| Other invested assets | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Cash and cash equivalents (restricted: 2023, $97,620; 2022: $137,782) | ||||||||||||||||||||
| Accrued investment income | ||||||||||||||||||||
| Reinsurance balances receivable (1) | ||||||||||||||||||||
| Reinsurance recoverable on paid and unpaid losses | ||||||||||||||||||||
| Prepaid reinsurance premiums | ||||||||||||||||||||
| Funds held by reinsured companies | ||||||||||||||||||||
| Deferred acquisition costs | ||||||||||||||||||||
| Market risk benefit assets, at fair value | ||||||||||||||||||||
| Deposit assets | ||||||||||||||||||||
| Net tax assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Non-life reserves (1) | ||||||||||||||||||||
| Life and health reserves (1) | ||||||||||||||||||||
| Market risk benefit liabilities, at fair value | ||||||||||||||||||||
| Unearned premiums (1) | ||||||||||||||||||||
| Other reinsurance balances payable (1) | ||||||||||||||||||||
| Debt | ||||||||||||||||||||
| Deposit liabilities | ||||||||||||||||||||
| Net tax liabilities | ||||||||||||||||||||
| Accounts payable, accrued expenses and other | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ Equity | ||||||||||||||||||||
| Common shares (par value $0.00000001; issued and outstanding: 100,000,000 shares) | ||||||||||||||||||||
| Preferred shares (par value $1.00; issued and outstanding: 8,000,000 shares; aggregate liquidation value: $200,000) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
Loading...
